NCT05495256View on ClinicalTrials.gov

Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

March 22, 2022

Study Completion Date

March 22, 2022

Conditions
AsthmaCopd
Interventions
DEVICE

Respimetrix

The Respimetrix device has a low resistance airflow sensor with an inhaler to measure patients inspiratory airflow and volume. This device will thereby provide quantifiable measures of lung function and bronchodilator delivery.

Trial Locations (1)

21286

Pulmonary and Critical Care Associates Of Baltimor, Towson

All Listed Sponsors
collaborator

Gerresheimer

UNKNOWN

lead

Pulmonary Critical Care Associates of Baltimore

OTHER